2023
DOI: 10.1016/j.cgh.2022.11.030
|View full text |Cite
|
Sign up to set email alerts
|

Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 62 publications
2
8
0
Order By: Relevance
“…[34] The results of this study confirm that blood LPS levels serve as a diagnostic biomarker for NAFLD, which can be used for disease detection, staging during disease progression, and as a substitute marker for enhanced intestinal permeability in NAFLD. [34] An imbalance in intestinal flora can lead to the destruction of gut barrier function and the development of NAFLD. And intestinal flora act a key role in regulating host immunity and metabolism.…”
Section: Spearman's Correlation Analysis Of Gut Microbiota Biochemica...supporting
confidence: 73%
See 1 more Smart Citation
“…[34] The results of this study confirm that blood LPS levels serve as a diagnostic biomarker for NAFLD, which can be used for disease detection, staging during disease progression, and as a substitute marker for enhanced intestinal permeability in NAFLD. [34] An imbalance in intestinal flora can lead to the destruction of gut barrier function and the development of NAFLD. And intestinal flora act a key role in regulating host immunity and metabolism.…”
Section: Spearman's Correlation Analysis Of Gut Microbiota Biochemica...supporting
confidence: 73%
“…A total of 34 studies were included in the study for meta‐analysis. The research results showed that the blood LPS levels in patients with simple steatosis were higher than those in the liver healthy control group (SMD=0.86, CI=0.62–1.11), and higher levels of LPS were observed in patients with higher histopathological grading of liver steatosis and fibrosis [34] . The results of this study confirm that blood LPS levels serve as a diagnostic biomarker for NAFLD, which can be used for disease detection, staging during disease progression, and as a substitute marker for enhanced intestinal permeability in NAFLD [34] …”
Section: Resultsmentioning
confidence: 89%
“…In addition, periodontal pathogens – mainly the Gram-negative anaerobic bacterium Porphyromonas gingivalis – are associated with leakage of endotoxin from the oral cavity into the bloodstream [27]. Notably, high levels of blood endotoxin have been related to more advanced grades of hepatic fibrosis in patients with NAFLD [28]. However, we cannot exclude that the occurrence of fatigue and physical frailty in patients with more advanced fibrosis stages may have impaired oral hygiene practices in our sample.…”
Section: Discussionmentioning
confidence: 99%
“…The lack of association between EndoCab and liver outcomes aligns with conclusions of a recent empirical study in similarly aged adolescents 14 and a 2022 systematic review and meta-analysis that reported elevations in circulating lipopolysaccharide and LBP among persons with hepatic steatosis and fibrosis but no consistent associations for EndoCab. 17 One explanation is low specificity of EndoCab as a marker of NAFLD, as this immunoglobulin can become elevated due to other common, unrelated conditions such as urinary tract infections and renal stones. 18 A second explanation is that the relationship of EndoCab with liver outcomes may be more readily detectable in populations with greater variation in cardiometabolic profile.…”
Section: Discussionmentioning
confidence: 99%